Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

NCT07397325 is registered in ClinicalTrials.gov with Applied Biology, Inc. as lead sponsor.

NCT NCT07397325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07397325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Lead sponsor
Applied Biology, Inc.
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 16, 2026
Completion date
March 5, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced alopecia, chemotherapy side effects